UNICYCIVE THERAPEUTICS, INC. Increase (Decrease) in Other Current Liabilities
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Increase (Decrease) in Other Current Liabilities of -$73.00 thousand for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2022-08-15
- UNICYCIVE THERAPEUTICS, INC. increase (decrease) in other current liabilities for the quarter ending 2022-06-30 was -$37.00K.
- UNICYCIVE THERAPEUTICS, INC. increase (decrease) in other current liabilities for the quarter ending 2022-03-31 was -$36.00K.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month |
|---|---|---|
| 2022-06-30 | -$37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$73.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$36.00K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |